Biotechnology in Taiwan
With the supporting infrastructure in place and with strong government backing, Taiwan is poised to become Asia's hub for the life sciences. A stepping stone to China, Taiwan is also the ideal proving ground for biotech-related products and services destined for the Greater China market as a whole. More...
Event Spotlight: 3rd World-China Biosimilars & Novel Vaccines Forum 2016, 16-17 March, Shanghai, China
Our featured event is the 3rd World-China Biosimilars & Novel Vaccine Forum (WCBVF), an international annual conference that provides a platform of technical exchange and strategic collaboration for Chinese biosimilar and vaccine players, Chinese regulators and global biopharmaceutical companies.
WCBVF has two streams; Biosimilars and Novel Vaccines. The event will cover the latest Chinese biosimilars and vaccine regulatory guidelines and provide in-depth discussions such issues as biosimilarity factors in up-down stream development; clinical trials for biosimilars; cutting-edge novel vaccine R&D progress worldwide; and best practices in quality control from discovery, development to industrialization in the area of novel vaccines. Visit the event website
New! Join our LinkedIn group
Join BiotechEast's group on the popular business networking website LinkedIn and help grow your network of Asian-focused life science professionals – more than 430 members so far! Join here